Emerald Bioscience, Inc.

Emerald Bioscience, Inc.
Subscribe to Updates: Emerald Bioscience, Inc. Updates
OTC Ticker Symbol: EMBI

Emerald Bioscience, Inc. (OTC:EMBI), formerly known as Nemus Bioscience, Inc. (OTC:NMUS) is a biopharmaceutical company headquartered in Long Beach, California, focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs in global markets. With proprietary technology licensed from the University of Mississippi, Emerald is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Emerald’s strategy is to clinically develop a number of proprietary biosynthetic compounds, alone or in combination with corporate partners. Emerald Bioscience is part of the Emerald Group, which comprises multiple companies focused on developing pharmaceutical, botanical, and nutraceutical products providing wellness and medical benefits by interacting with the human body’s endocannabinoid system.

ZIP Code: 90803
Business Website Address: https://www.emeraldbio.life/
Business Phone Number: 949-336-3437
Country: USA
State: California
  • Nemus Bioscience, Inc. (OTC:NMUS)